Causes of Elevated CA125

CA125 is a topic unfamiliar to many people. When CA125 levels are elevated, the underlying causes are often unclear, and diagnosis cannot be established based on this test alone. CA125 is actually a carbohydrate antigen; abnormal elevations may indicate malignant transformation—most commonly associated with cancers such as endometrial cancer and pancreatic cancer, which require prompt evaluation and management.

Causes of Elevated CA125

1. CA125 is a carbohydrate antigen serving as a tumor marker for multiple malignancies, including epithelial ovarian cancer, cervical cancer, uterine body cancer (endometrial cancer), pancreatic cancer, and others. Patients with these conditions often exhibit varying degrees of CA125 elevation. Normal reference ranges are <35 kU/L in males and <40 kU/L in females. However, an elevated CA125 level does not necessarily indicate malignancy. Clinically, certain benign gynecological conditions may also cause CA125 elevation. Therefore, definitive diagnosis requires additional diagnostic testing.

2. CA125 is a glycoprotein produced by the endometrium, cervix, and fallopian tubes. Elevated serum CA125 levels may occur when tissues in these organs sustain injury or inflammation. Common associated conditions include endometriosis, cervical cancer, and ovarian cancer. Additionally, CA125 may rise during pregnancy, menstruation, or in patients with hepatic disease. Although CA125 is considered a relatively specific biomarker for ovarian cancer, it may also increase in benign pelvic disorders—including pelvic inflammatory disease, endometritis, and ovarian cysts—though typically only mildly. Thus, mild CA125 elevation generally does not warrant excessive concern.

3. CA125 is a commonly used gynecologic tumor marker. Elevation of CA125 is frequently accompanied by concurrent increases in CA15-3 and carcinoembryonic antigen (CEA). Such patterns are commonly observed in gynecologic malignancies—including breast cancer, ovarian cancer, and endometrial cancer—as well as gastrointestinal cancers. If CA125 is found to be elevated, repeat testing is recommended after one month. Persistent elevation warrants suspicion for gynecologic or gastrointestinal malignancy, prompting further evaluation—including breast and pelvic ultrasound, as well as chest and abdominal CT imaging.

4. Generally speaking, CA125 is a widely utilized tumor marker in clinical practice, primarily employed for tumor detection and diagnosis. While trace amounts of CA125 are present on normal cells, significantly higher concentrations are observed in cancer patients—especially those with ovarian cancer, endometrial cancer, breast cancer, and occasionally hepatocellular carcinoma. Notably, CA125 elevation may also occur in benign conditions, rendering it non-specific. For instance, elevated CA125 levels are frequently seen in benign gynecologic disorders such as adenomyosis and endometriosis. Cervical inflammation is another common benign cause of CA125 elevation.

The above outlines the major causes of elevated CA125. We hope this information is helpful to you.